Doxorubicin Hydrochloride recalls

Doxorubicin Hydrochloride products have been recalled 3 times, most recently on 17 Jun 2026. The recalling company is usually Sun Pharmaceutical Industries. The most common reason is sterility.

Total recalls3since 2018

Last 12 months1reported

Class I133% of total

Ongoing1latest 17 Jun 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 1 0 0Aug 0 0

Severity split

Class I 1 33%Class II 1 33%Class III 1 33%

Why doxorubicin hydrochloride is recalled

Companies

Sun Pharmaceutical Industries267%
Fresenius Kabi USA133%

Product types

Injectable & IV Drugs3100%

By year

2026133%
2020133%
2018133%

Ongoing doxorubicin hydrochloride recalls

1 active

Reported	Class	Recall	Company	Reason	Where
17 Jun 2026Drug	CLASS I	DOXOrubin Hydrochloride Liposome injection, 50 mg recalledDoxorubicin Hydrochloride	SUN Pharmaceutical Industries	Particulate Matter	Nationwide

All doxorubicin hydrochloride recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
17 Jun 2026Drug	CLASS I	DOXOrubin Hydrochloride Liposome injection, 50 mg recalledDoxorubicin Hydrochloride	SUN Pharmaceutical Industries	Particulate Matter	Nationwide
2 Dec 2020Drug	CLASS III	DOXOrubicin Hydrochloride Injection, USP, 10 mg recalledDoxorubicin Hydrochloride	Fresenius Kabi USA	Other	Nationwide
31 Jan 2018Drug	CLASS II	DOXOrubicin Hydrochloride Liposome Injection, 20 mg recalledDoxorubicin Hydrochloride	Sun Pharmaceutical Industries	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.